Bay Shore Trust's Form 4 filing
Telomir Pharmaceuticals, Inc. (TELO) · filed Feb 15, 2024
- Accession no.
- 0000897069-24-000395
- Filed
- Feb 15, 2024, 4:11 PM ET
- Trade date
- Feb 13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $966.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bay Shore TrustCIK 0001986593 | 10% Owner |
| McNulty Brian PatrickCIK 0001996353 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | Common Stock | PPurchaseAcquired | +49,000 | $7.00 | +$343,000 | 5,455,431 | Indirect | |
| Feb 13, 2024 | Common Stock | PPurchaseAcquired | +40,000 | $7.00 | +$280,000 | 1,365,646 | Indirect | |
| Feb 13, 2024 | Common Stock | PPurchaseAcquired | +49,000 | $7.00 | +$343,000 | 1,902,659 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.